VALANX Biotech

VALANX Biotech

VALANX Biotech

Biotech start-up with a novel #protein #conjugation platform. Site-directed, fast and cost efficient. #antibodies #biosensor #biocatalysis #immobilisation
Type
B2c
Raised
$168.5k
Follow us
Alexa global traffic share
Twitter followers
Latest funding
€150,000
Grant - 2017
Austria Wirtschaftsservice
Team Size
1–10
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when VALANX Biotech makes some noise.